Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8+ T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation

Transplant Infectious Disease

Volumn 17, Issue 3, 2015, Pages 361-370

  Gimenez E ^a   Munoz Cobo B ^a   Solano, C ^a,b   Amat, P ^a   de la Camara R ^c   Nieto, J ^d   Lopez J ^e   Remigia, M J ^a   Garcia Noblejas, A ^c   Navarro, D ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d HOSPITAL MORALES MESEGUER   (Spain)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Allogeneic stem cell transplant; CMV DNAemia; Cytomegalovirus; Polyfunctional CD8+ T cells

Indexed keywords

CYCLOSPORIN; CYTOMEGALOVIRUS ANTIGEN PP65; FOSCARNET; GAMMA INTERFERON; GANCICLOVIR; IMMEDIATE EARLY PROTEIN; IMMEDIATE EARLY PROTEIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; METHOTREXATE; MYCOPHENOLATE MOFETIL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VALGANCICLOVIR; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; MATRIX PROTEIN; PHOSPHOPROTEIN; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR; VIRUS DNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIVIRAL THERAPY; ARTICLE; CD8+ T LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HUMAN; IMMUNOCOMPETENCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN FUNCTION; VIREMIA; VIRUS LOAD; ADVERSE EFFECTS; ALLOTRANSPLANTATION; BLOOD; COHORT ANALYSIS; CYTOMEGALOVIRUS; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; STEM CELL TRANSPLANTATION; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; PHOSPHOPROTEINS; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA; VIRAL MATRIX PROTEINS; YOUNG ADULT;

EID: 84930752823     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12391     Document Type: Article

References (32)

1. Solano C, Navarro D. Clinical virology of cytomegalovirus infection following hematopoietic transplantation. Future Virol 2010; 5 (2): 111-124.
2. Quinnan GV Jr, Kirmani N, Rook AH, et al. Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med 1982; 307 (1): 7-13.
3. Reusser P, Riddell SR, Meyers JD, Greenberg PD. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 1991; 78 (5): 1373-1380.
4. Li CR, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994; 83 (7): 1971-1979.
5. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg P. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992; 257 (5067): 238-241.
6. Einsele H, Roosnek E, Rufer N, et al. Infusion of cytomegalovirus (CMV)-specific T-cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 2002; 99 (11): 3916-3922.
7. Seggewiss R, Einsele H. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. Blood 2010; 115 (19): 3861-3868.
8. Krenger W, Blazar BR, Holländer GA. Thymic T-cell development in allogeneic stem cell transplantation. Blood 2011; 117 (25): 6768-6776.
9. + T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection. Haematologica 2008; 93 (9): 1434-1436.
10. + T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2010; 45 (3): 543-549.
11. Tormo N, Solano C, Benet I, et al. Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT. Bone Marrow Transplant 2011; 46 (11): 1437-1443.
12. + T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection. J Med Virol 2010; 82 (7): 1208-1215.
13. Harari A, Dutoit V, Cellerai C, Bart PA, Du Pasquier RA, Pantaleo G. Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev 2006; 211: 236-254.
14. Zhou W, Longmate J, Lacey SF, et al. Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients. Blood 2009; 113 (25): 6465-6476.
15. + T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients. J Med Virol 2012; 84 (2): 259-267.
16. Guerrero A, Riddell SR, Storek J, et al. Cytomegalovirus viral load and virus-specific immune reconstitution after peripheral blood stem cell versus bone marrow transplantation. Biol Blood Marrow Transplant 2012; 18 (1): 66-75.
17. Król L, Stuchlý J, Hubáreck P, et al. Signature profiles of CMV-specific T cells in patients with CMV reactivation after hematopoietic SCT. Bone Marrow Transplant 2011; 46 (8): 1089-1098.
18. Lacey S, La Rosa C, Zhou W, et al. Functional comparison of T cells recognizing cytomegalovirus pp65 and immediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients. J Infect Dis 2006; 194 (10): 1410-1421.
19. + T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection. Haematologica 2008; 93 (2): 248-256.
20. Gimeno C, Solano C, Latorre JC, et al. Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients. J Clin Microbiol 2008; 46 (10): 3311-3318.
21. Bravo D, Clari MÁ, Costa E, et al. Comparative evaluation of three automated systems for DNA extraction in conjunction with three commercially available real-time PCR assays for quantitation of plasma cytomegalovirus DNAemia in allogeneic stem cell transplant recipients. J Clin Microbiol 2011; 49 (8): 2899-2904.
22. + T cells. J Exp Med 2004; 199 (7): 925-936.
23. Bryceson YT, Pende D, Maul-Pavicic A, et al. A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. Blood 2012; 119 (12): 2754-2763.
24. Clari MÁ, Muñoz-Cobo B, Solano C, et al. Performance of the QuantiFERON-cytomegalovirus (CMV) assay for detection and estimation of the magnitude and functionality of the CMV-specific gamma interferon-producing CD8(+) T-cell response in allogeneic stem cell transplant recipients. Clin Vaccine Immunol 2012; 19 (5): 791-796.
25. Makedonas G, Hutnick N, Haney D, et al. Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells. PLoS Pathog 2010; 6 (3): e1000798.
26. + T cells protect against high-level replication after liver transplantation. Am J Transplant 2008; 8 (12): 2590-2599.
27. Lachmann R, Bajwa M, Vita S, et al. Polyfunctional T cells accumulate in large human cytomegalovirus-specific T cell responses. J Virol 2012; 86 (2): 1001-1009.
28. Solano C, Benet I, Remigia MJ, et al. Immunological monitoring for guidance of preemptive antiviral therapy for active cytomegalovirus infection in allogeneic stem-cell transplant recipients: a pilot experience. Transplantation 2011; 92 (4): e17-e20.
29. Shanley JD, Jordan MC, Cook ML, Stevens JG. Pathogenesis of reactivated latent murine cytomegalovirus infection. Am J Pathol 1979; 95 (1): 67-80.
30. + T cells dominate the memory compartments of exposed subjects. J Exp Med 2005; 202 (5): 673-685.
31. Han Q, Bagheri N, Bradshaw EM, Hafler DA, Lauffenburger DA, Love JC. Polyfunctional responses by human T cells result from sequential release of cytokines. Proc Natl Acad Sci USA 2012; 109 (5): 1607-1612.
32. + T cell phenotypes. Immunity 2012; 36 (1): 142-152.